Pharmaceutical News: Latest Indian Pharma, Medical & Healthcare Industry News
The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons. You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.
Pharma exports have crossed the US$ 3 billion mark from the state of Gujarat in the span of the last ten years.
January 7, 2017: Gujarat features among the top pharmaceutical manufacturing hubs in India with around 35 per cent share in national production and 28 per cent of pharmaceutical exports.
Biologics, also known as biopharmaceuticals have entered the list of the top 10 selling drugs, with seven of them featuring in it.
December 28, 2016: They have been revolutionary in the treatment of serious illnesses like rheumatoid arthritis, cancers and diabetes.
Indian pharma companies would be engaging in more Mergers and Acquisitions (M&As) in the coming next two years not only in the US market but also in emerging markets like Russia, Africa and Latin America according to research by Moody’s Investors Service.
December 13, 2016: Due to moderating organic growth rates and stagnant profitability in recent times, Indian pharma...
The Indian pharmaceutical industry is expected to grow at a sluggish pace due to slower growth in the US market, rise in competition and saturated adoption of generics as per rating agency, ICRA.
December 09, 2016: The growth in the US market has fallen to 9 per cent in the first half of 2016-17 and is expected to be under further pressure in the future.
Global generic pharmaceutical company Mylan and Indian biotechnology firm, Biocon have given a submission of Biologics Licence Application (BLA) for proposed biosimilar, trastuzumab to the US Food and Drug Administration (FDA).
November 8, 2016: The product MYL-1401O has been proposed for the branded trastuzumab used for treating certain HER2-positive breast and gastric ...